AbbVie
Search results
Jun 10, 2024 · Aug. 21, 2024. Report Finds Abbott is Most Profitable Healthcare Stock of All Time. Abbott is No. 1 in healthcare and No. 11 overall in an Arizona State University report analyzing long-term returns for publicly traded companies. July 18, 2024.
Abbott Expands its Pure Bliss™ Line of Infant Formulas to Include European-Made and Organic Products; Offers the First and Only Organic Liquid Formula Available at U.S. Retail Stores. Aug 21, 2024.
Jun 10, 2024 · Abbott announces two new over-the-counter continuous glucose monitoring (CGM) systems – Lingo and Libre Rio – based on its world-leading FreeStyle Libre technology. Lingo is for consumers who want to improve their health and wellness, and Libre Rio is for adults with Type 2 diabetes who do not use insulin.
Jan 24, 2024 · Abbott reports double-digit organic sales growth and EPS exceeding guidance in Q4 2023, driven by Medical Devices and Nutrition. The company also projects 8-10% organic sales growth and $4.50-$4.70 EPS for 2024.
Jan 24, 2024 · ABBOTT PARK, Ill., Jan. 24, 2024 / PRNewswire / -- Abbott today announced financial results for the fourth quarter ended Dec. 31, 2023. Fourth-quarter sales increased 1.5 percent on a reported basis, 2.1 percent on an organic basis, and 11.0 percent on an organic basis, excluding COVID-19 testing-related sales 1.
Jan 25, 2023 · Demonstrating this, Abbott significantly exceeded the earnings per share (EPS) guidance it provided at the start of 2022. Contributing to this success was strong performance across multiple businesses during the fourth quarter as the pandemic continued to ease.
Apr 17, 2024 · Wednesday, Abbott Laboratories (NYSE:ABT) reported first-quarter sales of $9.96 billion, up 10.8% on an organic basis for the underlying base business, beating the consensus of $9.88 billion.
